The Resource Comparative effectiveness of angiotensin converting enzyme inhibitors or angiotensin II receptor blockers added to standard medical therapy for treating stable ischemic heart disease, prepared for Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by University of Connecticut/Hartford Hospital Evidence-based Practice Center ; Craig I. Coleman ... [et al.], (electronic book)

Comparative effectiveness of angiotensin converting enzyme inhibitors or angiotensin II receptor blockers added to standard medical therapy for treating stable ischemic heart disease, prepared for Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by University of Connecticut/Hartford Hospital Evidence-based Practice Center ; Craig I. Coleman ... [et al.], (electronic book)

Label
Comparative effectiveness of angiotensin converting enzyme inhibitors or angiotensin II receptor blockers added to standard medical therapy for treating stable ischemic heart disease
Title
Comparative effectiveness of angiotensin converting enzyme inhibitors or angiotensin II receptor blockers added to standard medical therapy for treating stable ischemic heart disease
Statement of responsibility
prepared for Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by University of Connecticut/Hartford Hospital Evidence-based Practice Center ; Craig I. Coleman ... [et al.]
Contributor
Subject
Language
  • eng
  • eng
Summary
This is an evidence report prepared by the University of Connecticut/Hartford Hospital Evidence-based Practice Center (EPC) concerning the benefits and harms associated with using angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), either alone or in combination, in people with stable ischemic heart disease or ischemic heart disease risk equivalents and intact left ventricular systolic function. While the role of ACE inhibitors and ARBs in patients with post-myocardial infarction left ventricular dysfunction or chronic heart failure is well established, the role for these modalities in patients with stable ischemic heart disease or ischemic heart disease risk equivalents and preserved left ventricular systolic function is not as clear. The aim of this report is to acquire, assess, and summarize the current evidence about the benefits and harms associated with the use of ACE inhibitors and ARBs, either alone or in combination, in this patient population. The information is intended to inform clinicians, payors, and the public, while helping to define avenues for future research
Member of
Cataloging source
DNLM
Government publication
federal national government publication
Illustrations
illustrations
Index
no index present
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
http://library.link/vocab/relatedWorkOrContributorName
  • Coleman, Craig I
  • United States
  • University of Connecticut-Hartford Hospital Evidence-based Practice Center
Series statement
  • Comparative effectiveness review
  • AHRQ publication
Series volume
  • 18
  • 10-EHC002-EF
http://library.link/vocab/subjectName
  • Myocardial Ischemia
  • Angiotensin-Converting Enzyme Inhibitors
  • Angiotensin Receptor Antagonists
  • Treatment Outcome
  • Evidence-Based Medicine
  • United States
Label
Comparative effectiveness of angiotensin converting enzyme inhibitors or angiotensin II receptor blockers added to standard medical therapy for treating stable ischemic heart disease, prepared for Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by University of Connecticut/Hartford Hospital Evidence-based Practice Center ; Craig I. Coleman ... [et al.], (electronic book)
Instantiates
Publication
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Control code
1559525
Dimensions
unknown
Extent
1 online resource (1 PDF file (1 v. (various pagings)))
Form of item
online
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Specific material designation
remote
Label
Comparative effectiveness of angiotensin converting enzyme inhibitors or angiotensin II receptor blockers added to standard medical therapy for treating stable ischemic heart disease, prepared for Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services ; prepared by University of Connecticut/Hartford Hospital Evidence-based Practice Center ; Craig I. Coleman ... [et al.], (electronic book)
Publication
Bibliography note
Includes bibliographical references
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Control code
1559525
Dimensions
unknown
Extent
1 online resource (1 PDF file (1 v. (various pagings)))
Form of item
online
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Specific material designation
remote

Library Locations

Processing Feedback ...